{
    "paper_id": "PMC7172573",
    "metadata": {
        "title": "Angiotensin II for the Treatment of COVID-19\u2013Related Vasodilatory Shock",
        "authors": [
            {
                "first": "Jonathan",
                "middle": [
                    "H."
                ],
                "last": "Chow",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Michael",
                "middle": [
                    "A."
                ],
                "last": "Mazzeffi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Michael",
                "middle": [
                    "T."
                ],
                "last": "McCurdy",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Name: Jonathan H. Chow, MD.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "Contribution: This author helped analyze the data, write the manuscript, and edit the manuscript.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "Conflicts of Interest: J. H. Chow serves on the Speaker\u2019s Bureau for La Jolla Pharmaceutical Company.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "Name: Michael A. Mazzeffi, MD, MPH.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "Contribution: This author helped analyze the data, write the manuscript, and edit the manuscript.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "Conflicts of Interest: None.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "Name: Michael T. McCurdy, MD.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "Contribution: This author helped analyze the data, write the manuscript, and edit the manuscript.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "Conflicts of Interest: None.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        },
        {
            "text": "This manuscript was handled by: Jean-Francois Pittet, MD.",
            "cite_spans": [],
            "section": "DISCLOSURES",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure 1.: Normal function of ACE. ACE hydrolyzes Ang-1 into Ang-2, which then acts on AT1 receptors to cause vasoconstriction. ACE is also required at 2 points in the hydrolysis of bradykinin into bradykinin-(1\u20137) and bradykinin-(1\u20135). ACE indicates angiotensin-converting enzyme; Ang-1, angiotensin I; Ang-2, angiotensin II; AT1, angiotensin type 1.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2.: Effect of ACE dysfunction on metabolite accumulation. Dysfunction in ACE as a result of endothelial damage, ARDS, and septic shock prevents the hydrolysis of Ang-1 to Ang-2 from occurring. Ang-1 accumulates, and the excess is metabolized into Ang-(1\u20139) and Ang-(1\u20137). Ang-(1\u20137) leads to activation of nitric oxide synthase and agonism of AT2, B2, and MAS receptors, which all lead to vasodilatation. In addition, ACE dysfunction prevents the degradation of bradykinin into bradykinin-(1\u20137) and bradykinin-(1\u20135), which results in an excessive accumulation of bradykinin and potent vasodilatation. The figure was created with Motifolio Toolkit (Motifolio Inc, Ellicott City, MD). ACE indicates angiotensin-converting enzyme; Ang-(1\u20137), angiotensin-(1\u20137); Ang-(1\u20139), angiotensin-(1\u20139); Ang-1, angiotensin I; Ang-2, angiotensin II; ARDS, acute respiratory distress syndrome; AT2, angiotensin type 2; MAS, mitochondrial assembly protein;RAAS, renin-angiotensin-aldosterone system.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Clinical characteristicsof coronavirus disease2019 in China.",
            "authors": [
                {
                    "first": "WJ",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "ZY",
                    "middle": [],
                    "last": "Ni",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Reversal of vasodilatory shock: current perspectiveson conventional, rescue, and emerging vasoactive agentsfor the treatmentof shock.",
            "authors": [
                {
                    "first": "JH",
                    "middle": [],
                    "last": "Chow",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Abuelkasem",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sankova",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Henderson",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Mazzeffi",
                    "suffix": ""
                },
                {
                    "first": "KA",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Anesth Analg",
            "volume": "130",
            "issn": "",
            "pages": "15-30",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Renin as a markerof tissue- perfusionand prognosisin critically ill patients.",
            "authors": [
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Gleeson",
                    "suffix": ""
                },
                {
                    "first": "IA",
                    "middle": [],
                    "last": "Crippa",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Mongkolpun",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Crit Care Med",
            "volume": "47",
            "issn": "",
            "pages": "152-158",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Angiotensin-(1-7).",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Hypertension",
            "volume": "63",
            "issn": "",
            "pages": "1138-1147",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Tom",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dendorfer",
                    "suffix": ""
                },
                {
                    "first": "AH",
                    "middle": [],
                    "last": "Danser",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Int J Biochem Cell Biol",
            "volume": "35",
            "issn": "",
            "pages": "792-801",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans.",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hornig",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Kohler",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Drexler",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Circulation",
            "volume": "95",
            "issn": "",
            "pages": "1115-1118",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Angiotensin II for the treatmentof vasodilatory shock.",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Khanna",
                    "suffix": ""
                },
                {
                    "first": "SW",
                    "middle": [],
                    "last": "English",
                    "suffix": ""
                },
                {
                    "first": "XS",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "N Engl J Med",
            "volume": "377",
            "issn": "",
            "pages": "419-430",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wrapp",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "KS",
                    "middle": [],
                    "last": "Corbett",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Science",
            "volume": "367",
            "issn": "",
            "pages": "1260-1263",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.",
            "authors": [
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Deshotels",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sriramula",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lazartigues",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Filipeanu",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Hypertension",
            "volume": "64",
            "issn": "",
            "pages": "1368-1375",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Koka",
                    "suffix": ""
                },
                {
                    "first": "XR",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "LD",
                    "middle": [],
                    "last": "Truong",
                    "suffix": ""
                },
                {
                    "first": "HY",
                    "middle": [],
                    "last": "Lan",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am J Pathol",
            "volume": "172",
            "issn": "",
            "pages": "1174-1183",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bellomo",
                    "suffix": ""
                },
                {
                    "first": "RG",
                    "middle": [],
                    "last": "Wunderink",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Szerlip",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Crit Care",
            "volume": "24",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.",
            "authors": [
                {
                    "first": "KR",
                    "middle": [],
                    "last": "Ham",
                    "suffix": ""
                },
                {
                    "first": "DW",
                    "middle": [],
                    "last": "Boldt",
                    "suffix": ""
                },
                {
                    "first": "MT",
                    "middle": [],
                    "last": "McCurdy",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Ann Intensive Care",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Effect of disease severityon survivalin patients receiving angiotensinII for vasodilatory shock.",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Szerlip",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bihorac",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Crit Care Med",
            "volume": "46",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Outcomes in patientswith vasodilatory shockand renal replacement therapy treatedwith intravenous angiotensinII.",
            "authors": [
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Tumlin",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Murugan",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Deane",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Crit Care Med",
            "volume": "46",
            "issn": "",
            "pages": "949-957",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Baseline angiotensin levelsand ACE effectsin patientswith vasodilatory shock treatedwith angiotensinII.",
            "authors": [
                {
                    "first": "RG",
                    "middle": [],
                    "last": "Wunderink",
                    "suffix": ""
                },
                {
                    "first": "TE",
                    "middle": [],
                    "last": "Albertson",
                    "suffix": ""
                },
                {
                    "first": "LW",
                    "middle": [],
                    "last": "Busse",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Intensive Care Med Exp",
            "volume": "5",
            "issn": "suppl2",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "The acute respiratory distress syndrome.",
            "authors": [
                {
                    "first": "LB",
                    "middle": [],
                    "last": "Ware",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Matthay",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "N Engl J Med",
            "volume": "342",
            "issn": "",
            "pages": "1334-1349",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Angiotensin converting enzyme defects in shock: implications for future therapy.",
            "authors": [
                {
                    "first": "LS",
                    "middle": [],
                    "last": "Chawla",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bellomo",
                    "suffix": ""
                },
                {
                    "first": "GF",
                    "middle": [],
                    "last": "Tidmarsh",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Crit Care",
            "volume": "22",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}